Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT00935714Unknown
-
NCT05964504RecruitingMetastatic Breast Cancer | Lobular Breast Carcinoma
-
NCT04687956RecruitingBreast Cancer | Lymphedema | Mastectomy
-
NCT05751668SuspendedAnatomic Stage IV Breast Cancer AJCC v8 | Chemotherapy-Induced Peripheral Neuropathy | Metastatic Breast Carcinoma
-
NCT06065423CompletedTelerehabilitation | Breast Cancer Related Lymphedema
-
NCT03391206CompletedBreast Cancer Lymphedemas
-
NCT00998738TerminatedPain | Neuropathy | Stage IV Breast Cancer | Recurrent Breast Carcinoma
-
NCT05417867RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Early Stage Breast Carcinoma | Chemotherapy-Related Nausea and/or Vomiting
-
NCT01048918CompletedLocally Advanced Breast Cancer | Metastatic (Stage IV) Breast Cancer | Stage III-IV Breast Cancer or Inflammatory
-
NCT07292246RecruitingBreast Cancer | Breast Neoplasms | Early Breast Cancer | DCIS | BRCA 1 Gene Mutation | BRCA 2 Gene Mutation | Germline Mutation Abnormality | Hereditary Breast Carcinoma
-
NCT07095114RecruitingStage I Breast Cancer | Stage II Breast Cancer | Ductal Carcinoma in Situ | Stage III Breast Cancer
-
-
NCT06157892RecruitingStomach Neoplasms | Breast Neoplasms | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Neoplasms | Metastatic Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Cancer | HER2 Positive Breast Neoplasms | HER2 Low Breast Neoplasms
-
NCT06115486RecruitingBreast Cancer | Breast Cancer Female | Breast Carcinoma in Situ
-
NCT03749850RecruitingBreast Cancer | Breast Neoplasms | Metastatic Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Invasive Ductal Breast Cancer | Invasive Ductal Carcinoma of Female Breast | Adenocarcinoma Breast
-
NCT00098605CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | Central Nervous System Metastases | Tumors Metastatic to Brain
-
NCT03284346TerminatedObesity | Overweight | Sedentary Lifestyle | Stage I Breast Cancer | Cancer Survivor | Prostate Carcinoma | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer
-
NCT07020806RecruitingMetastatic Lobular Breast Carcinoma
-
NCT06095323RecruitingBreast Cancer-related Arm Lymphedema
-
NCT04824378RecruitingBreast Cancer Related Lymphedema | Deep Learning
-
NCT06663787Active, not recruitingBreast Cancer, Metastatic | HER2 + Breast Cancer
-
NCT06343987CompletedMetastatic Breast Cancer | Adiposity | Estrogen-receptor-positive Breast Cancer
-
-
NCT00694577Completed
-
NCT00573495CompletedBreast Cancer | Breast Neoplasm | Carcinoma, Ductal | Cancer of the Breast
-
NCT00106002CompletedBreast Cancer | Breast Neoplasms, Male | Carcinoma, Ductal
-
NCT06846437RecruitingUnrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants
-
NCT06856200RecruitingAdvanced HR - Positive, HER2 - Negative Breast Cancer | Resistant to (Neo)Adjuvant Endocrine Therapy
-
NCT06629896RecruitingBreast Cancer Screening and Diagnosis
-
NCT06358625Recruiting
-
NCT06133088RecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
-
NCT05181202RecruitingLiposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
-
NCT03861975Active, not recruiting
-
-
NCT04880369WithdrawnBreast Cancer | Breast Neoplasms | Breast Cancer Female
-
NCT04441099TerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer
-
NCT01147484CompletedRecurrent Breast Cancer
-
NCT03462251CompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast Cancer
-
NCT01904903CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast Cancer
-
NCT01984866TerminatedTriple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients
-
NCT01446159CompletedHormone-sensitive, HER-2 Negative Metastatic Breast Cancer
-
NCT01996410TerminatedBreast Cancer Stages I Through III
-
NCT07582887RecruitingBreast Cancer | Metastatic Breast Cancer | Drug-Related Side Effects and Adverse Reactions | Pharmacogenetic Variant
-
NCT07011823Not yet recruitingTriple-Negative Breast Neoplasm
-
NCT06557057RecruitingHER2-Positive Breast Carcinoma
-
NCT05852743Not yet recruitingMonitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy Using SE and SWE
-
NCT03946423Not yet recruitingObesity | Early-stage Breast Cancer
-
NCT06087237CompletedBreast Cancer Surgery | Post-Surgical Complication
-
NCT03636776TerminatedMetastatic Breast Cancer | Positive Hormonal Receptors
-
NCT02843126CompletedRecurrent Breast Cancer
-
NCT07080476RecruitingBreast Cancer Related Lymphedema | Breast Cancer Related Lymphoedema | Truncal Lymphedema | Breast Edema
-
NCT03941756RecruitingMelanoma | Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Breast Inflammatory Carcinoma
-
NCT03725436CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast Cancer AJCC v8 | Prognostic Stage IIIC Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm